Overview

A Study to Evaluate AG-881 in Healthy Japanese and Non-Asian Participants

Status:
Completed
Trial end date:
2019-12-18
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the pharmacokinetics (PK) and safety of AG-881 in healthy Japanese and Non-Asian participants after single oral doses of 10 mg and 50 mg of AG-881.
Phase:
Phase 1
Details
Lead Sponsor:
Agios Pharmaceuticals, Inc.